(VIANEWS) – RANA GRUBER (RANA.OL), SPAREBANKEN ØST (SPOG.OL), SODEXO (SW.PA) are the highest payout ratio stocks on this list.
We have collected information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. RANA GRUBER (RANA.OL)
96.25% Payout Ratio
Rana Gruber AS engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber AS was founded in 1937 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr7.3.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 7.74. Meaning, the purchaser of the share is investing kr7.74 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.94%.
Volume
Today’s last reported volume for RANA GRUBER is 99958 which is 38.04% below its average volume of 161332.
Moving Average
RANA GRUBER’s worth is under its 50-day moving average of kr59.57 and way above its 200-day moving average of kr48.28.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 522.6% and a drop 34.4% for the next.
More news about RANA GRUBER.
2. SPAREBANKEN ØST (SPOG.OL)
81.36% Payout Ratio
Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; mortgages on homes; and debenture financing for second-hand cars, as well as services in the areas of financing, savings and investment, and money-transfer. It also distributes insurance, fund shares, interest rate hedging, and currency, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr6.62.
PE Ratio
SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 6.72. Meaning, the purchaser of the share is investing kr6.72 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.25%.
Moving Average
SPAREBANKEN ØST’s value is below its 50-day moving average of kr49.29 and under its 200-day moving average of kr48.85.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 25, 2022, the estimated forward annual dividend rate is 3.85 and the estimated forward annual dividend yield is 7.43%.
Yearly Top and Bottom Value
SPAREBANKEN ØST’s stock is valued at kr44.50 at 01:10 EST, way under its 52-week high of kr63.20 and above its 52-week low of kr43.90.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 691.4M for the twelve trailing months.
More news about SPAREBANKEN ØST.
3. SODEXO (SW.PA)
66.89% Payout Ratio
Sodexo S.A. develops, manages, and delivers on-site, benefits and rewards, and personal and home services worldwide. It provides various on-site services, which includes corporate Services, energy and resources, government and agencies, sports and leisure, and other services; healthcare and seniors; and learning solutions to schools and universities. The company also provides food services comprising retail services and brands, food delivery, and meal and food vouchers, as well as digital food ordering services; benefits and rewards services, such as employee benefits, incentive and recognition programs, employee mobility, expense management, and public benefits; and personal and home services, including childcare, concierge, and in-home care services for seniors and their families. In addition, it offers facility management services, including technical service management, assets management, building maintenance, access control, deep cleaning, energy management, space planning, project management, front-of-house services, grounds maintenance, waste management, HVAC systems, mail management, commercial cleaning, workspace management and pest control. services. The company was formerly known as Sodexho Alliance and changed its name to Sodexo S.A. in 2008. Sodexo S.A. was founded in 1966 and is headquartered in Issy-les-Moulineaux, France.
Earnings Per Share
As for profitability, SODEXO has a trailing twelve months EPS of €-4.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.53%.
Moving Average
SODEXO’s value is below its 50-day moving average of €88.43 and above its 200-day moving average of €83.06.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 23, 2022, the estimated forward annual dividend rate is 2.4 and the estimated forward annual dividend yield is 2.78%.
More news about SODEXO.
4. UCB (UCB.BR)
60.47% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €3.77.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 20.82. Meaning, the purchaser of the share is investing €20.82 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.
More news about UCB.
